Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models

With these strong preclinical results, Inovio plans to initiate a phase I/IIa clinical trial next year .

http://www.hispanicbusiness.com/2013/8/22/inovio_pharmaceuticals_malaria_dna_vaccine_demonstrates.htm